Enrollment Complete for Phase 3 Study Evaluating Brensocatib for Non-CF Bronchiectasis
People living with bronchiectasis, a chronic condition characterized by damaged airways, experience progressive lung damage and inflammation. This can lead to a multitude of consequences, including a reduction in…